Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 3
1985 3
1986 2
1987 3
1988 3
1989 7
1990 6
1991 6
1992 12
1993 10
1994 6
1995 13
1996 11
1997 9
1998 7
1999 12
2000 9
2001 9
2002 8
2003 8
2004 4
2005 14
2006 6
2007 5
2008 11
2009 10
2010 7
2011 9
2012 8
2013 12
2014 4
2015 4
2016 2
2017 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
A gene-expression signature as a predictor of survival in breast cancer.
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. van de Vijver MJ, et al. Among authors: rodenhuis s. N Engl J Med. 2002 Dec 19;347(25):1999-2009. doi: 10.1056/NEJMoa021967. N Engl J Med. 2002. PMID: 12490681 Free article.
Drug resistance.
Rodenhuis S. Rodenhuis S. Curr Opin Oncol. 1989 Dec;1(2):236-40. Curr Opin Oncol. 1989. PMID: 2489966 Review. No abstract available.
Clinical pharmacokinetics of cyclophosphamide.
de Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH. de Jonge ME, et al. Among authors: rodenhuis s. Clin Pharmacokinet. 2005;44(11):1135-64. doi: 10.2165/00003088-200544110-00003. Clin Pharmacokinet. 2005. PMID: 16231966 Review.
High-dose chemotherapy regimens for solid tumors.
van der Wall E, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: rodenhuis s. Cancer Treat Rev. 1995 Mar;21(2):105-32. doi: 10.1016/0305-7372(95)90023-3. Cancer Treat Rev. 1995. PMID: 7758003 Review.
The ras oncogenes in human lung cancer.
Rodenhuis S, Slebos RJ. Rodenhuis S, et al. Am Rev Respir Dis. 1990 Dec;142(6 Pt 2):S27-30. doi: 10.1164/ajrccm/142.6_Pt_2.S27. Am Rev Respir Dis. 1990. PMID: 2252272 Review.
Prognostic factors in NSCLC. Recent experiences.
van Zandwijk N, Mooi WJ, Rodenhuis S. van Zandwijk N, et al. Among authors: rodenhuis s. Lung Cancer. 1995 Apr;12 Suppl 1:S27-33. doi: 10.1016/0169-5002(95)00418-z. Lung Cancer. 1995. PMID: 7551931 Review.
234 results